Interactions between medical residents and drug companies: a national survey after the Mediator® affair.

by François Montastruc, Guillaume Moulis, Aurore Palmaro, Virginie Gardette, Geneviève Durrieu, Jean-Louis Montastruc
Published 2014-01-01

Serious Neurological Adverse Events of Ceftriaxone

by Clémence Lacroix, Annie-Pierre Bera-Jonville, François Montastruc, Lionel Velly, Joëlle Micallef, Romain Guilhaumou
Published 2021-05-01

Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database

by Alexis Revet, François Montastruc, Anne Roussin, Jean-Philippe Raynaud, Maryse Lapeyre-Mestre, Thi Thu Ha Nguyen
Published 2020-06-01

Cancer risk of anti-TNF-α at recommended doses in adult rheumatoid arthritis: a meta-analysis with intention to treat and per protocol analyses.

by Guillaume Moulis, Agnès Sommet, Johana Béné, François Montastruc, Laurent Sailler, Jean-Louis Montastruc, Maryse Lapeyre-Mestre
Published 2012-01-01

Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controll...

by Gilles Defer, Florian Le Caignec, Sophie Fedrizzi, François Montastruc, Damien Chevanne, Jean-Jacques Parienti, Laure Peyro-Saint-Paul
Published 2018-03-01